Max Healthcare Q3 FY26: PAT up 26% YoY, revenue grows 11%
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty 100 and 2.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Max Healthcare reported Q3 FY26 consolidated revenue of Rs 2,067.5 crores (up 10.6% YoY) and PAT of Rs 300.9 crores (up 26% YoY). 9M FY26 revenue rose 21.7% to Rs 6,230.6 crores with PAT up 45% to Rs 1,100.2 crores. Exceptional items of Rs 48.2 crores include Rs 33.9 crores for new Labour Codes and Rs 14.3 crores stamp duty provision on merger. Board approved adding 260 beds at Max Dwarka via services agreement amendment with Rs 25 crores refundable deposit funded internally. Auditor issued unmodified review report.
Strong Q3 with revenue up 11% and PAT up 26% YoY. Bed expansion at Dwarka supports future growth. Labour Code charge is one-time.